跨美迪克斯医疗 TMDX
$88.24 +$19.26 (+27.92%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $87.79 -0.51%
开盘$79.12
昨收$68.98
当日区间$76.50 – $88.44
成交量3.95M
市值$3.06B
市盈率（TTM）24.0
股息率–
财报
财报日平均波动±16.1%近16次财报
收涨次数9 / 1656% 的概率
最佳反应+51.2%
最差反应-29.9%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 4 Aug 2026 | After Market | ±15.6% | -5.28% | 符合区间 |
| 2026/Q1 | 5 May 2026 | After Market | ±12.9% | -23.19% | 超出定价预期 |
| 2025/Q4 | 24 Feb 2026 | After Market | ±16.0% | -4.30% | 符合区间 |
| 2025/Q3 | 29 Oct 2025 | After Market | ±17.5% | +1.09% | 符合区间 |
| 2025/Q2 | 30 Jul 2025 | After Market | ±19.0% | +10.46% | 符合区间 |
| 2025/Q1 | 8 May 2025 | After Market | ±19.3% | +19.64% | 超出定价预期 |
| 2024/Q4 | 27 Feb 2025 | After Market | ±27.3% | +5.82% | 符合区间 |
| 2024/Q3 | 28 Oct 2024 | After Market | ±24.8% | -29.90% | 超出定价预期 |
| 2024/Q1 | 30 Apr 2024 | After Market | ±18.7% | +24.93% | 超出定价预期 |
| 2023/Q4 | 26 Feb 2024 | After Market | ±27.5% | +14.11% | 符合区间 |
| 2023/Q3 | 6 Nov 2023 | After Market | ±20.8% | +51.18% | 超出定价预期 |
| 2023/Q2 | 3 Aug 2023 | After Market | ±16.8% | -8.31% | 符合区间 |
| 2023/Q1 | 1 May 2023 | After Market | ±14.5% | -5.18% | 符合区间 |
| 2022/Q4 | 22 Feb 2023 | After Market | ±17.5% | +20.55% | 超出定价预期 |
| 2022/Q3 | 3 Nov 2022 | After Market | ±23.6% | +24.00% | 超出定价预期 |
| 2022/Q2 | 1 Aug 2022 | After Market | ±16.6% | -10.34% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$189.95M+20.7% YoY
营业利润$23.74M-35.1% YoY
净利润$14.68M-57.9% YoY
摊薄每股收益$0.41-55.4% YoY
自由现金流$10.22M-87.6% YoY
经营现金流$17.31M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率58.7%
营业利润率12.2%
净利率22.7%
净资产收益率36.3%
资产收益率12.9%
投入资本回报率14.8%
流动比率6.62
负债/资产比率64.6%
现金及投资$472.68M
总负债$864.07M
净现金（净负债）-$391.40M
自由现金流/营收11.8%
暂无评论——快来第一个聊聊 TMDX。